WO2002031132A3 - 8843, a human dual specificity phosphatase family member and uses therefor - Google Patents
8843, a human dual specificity phosphatase family member and uses therefor Download PDFInfo
- Publication number
- WO2002031132A3 WO2002031132A3 PCT/US2001/031661 US0131661W WO0231132A3 WO 2002031132 A3 WO2002031132 A3 WO 2002031132A3 US 0131661 W US0131661 W US 0131661W WO 0231132 A3 WO0231132 A3 WO 0231132A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dual specificity
- specificity phosphatase
- family member
- uses therefor
- phosphatase family
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002211597A AU2002211597A1 (en) | 2000-10-11 | 2001-10-10 | 8843, a human dual specificity phosphatase family member and uses therefor |
EP01979662A EP1402010A2 (en) | 2000-10-11 | 2001-10-10 | 8843, a human dual specificity phosphatase family member and uses therefor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68667300A | 2000-10-11 | 2000-10-11 | |
US09/686,673 | 2000-10-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002031132A2 WO2002031132A2 (en) | 2002-04-18 |
WO2002031132A3 true WO2002031132A3 (en) | 2003-03-13 |
Family
ID=24757266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/031661 WO2002031132A2 (en) | 2000-10-11 | 2001-10-10 | 8843, a human dual specificity phosphatase family member and uses therefor |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1402010A2 (en) |
AU (1) | AU2002211597A1 (en) |
WO (1) | WO2002031132A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015658A2 (en) * | 1997-09-23 | 1999-04-01 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
WO2000018890A2 (en) * | 1998-09-30 | 2000-04-06 | Millennium Pharmaceuticals, Inc. | Protein phosphatase molecules and uses therefor |
WO2001055301A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001092491A2 (en) * | 2000-05-30 | 2001-12-06 | Sugen, Inc. | Mammalian protein phosphatases identified by in-silico analysis |
-
2001
- 2001-10-10 WO PCT/US2001/031661 patent/WO2002031132A2/en active Application Filing
- 2001-10-10 EP EP01979662A patent/EP1402010A2/en not_active Withdrawn
- 2001-10-10 AU AU2002211597A patent/AU2002211597A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015658A2 (en) * | 1997-09-23 | 1999-04-01 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
WO2000018890A2 (en) * | 1998-09-30 | 2000-04-06 | Millennium Pharmaceuticals, Inc. | Protein phosphatase molecules and uses therefor |
WO2001055301A2 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001055163A1 (en) * | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
WO2001092491A2 (en) * | 2000-05-30 | 2001-12-06 | Sugen, Inc. | Mammalian protein phosphatases identified by in-silico analysis |
Non-Patent Citations (5)
Title |
---|
DATABASE GSP [online] 17 December 2001 (2001-12-17), ROSEN CA ET AL: "Novel human enzyme polypeptide #606", XP002222369, retrieved from EBI Database accession no. AAU23520 * |
DATABASE GSP [online] 4 December 2001 (2001-12-04), ROSEN CA ET AL: "Novel human neoplastic disease associated polypeptide #141", XP002222370, retrieved from EBI Database accession no. AAU21708 * |
DATABASE GSP [online] 4 December 2001 (2001-12-04), ROSEN CA ET AL: "Novel human neoplastic disease associated polypeptide #258.", XP002222371, retrieved from EBI Database accession no. AAU21825 * |
FAUMAN E B ET AL: "Structure and function of the protein tyrosine phosphatases", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 21, no. 11, 1 November 1996 (1996-11-01), pages 413 - 417, XP004071016, ISSN: 0968-0004 * |
MARTELL K J ET AL: "THE VH1-LIKE DUAL-SPECIFICITY PROTEIN TYROSINE PHOSPHATASES", MOLECULAR AND CELLS, KOREAN SOCIETY FOR MOLECULAR SOCIETY, KR, vol. 8, no. 1, 28 February 1998 (1998-02-28), pages 2 - 11, XP001057593 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002031132A2 (en) | 2002-04-18 |
EP1402010A2 (en) | 2004-03-31 |
AU2002211597A1 (en) | 2002-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001070977A3 (en) | Fibroblast growth factor receptor-like molecules and uses thereof | |
WO1999054459A8 (en) | Nucleic acid molecules with novel chemical compositions capable of modulating gene expression | |
WO2003012057A3 (en) | Antisense modulation of serum amyloid a4 expression | |
WO1999036550A3 (en) | Human protease molecules | |
WO1999038972A3 (en) | Human genes and gene expression products ii | |
WO2000028090A3 (en) | Diagnostic assay for cancer | |
WO1999053061A3 (en) | Tumor associated nucleic acids and uses therefor | |
WO2001061007A3 (en) | Fibroblast growth factor-23 molecules and uses thereof | |
WO2001068854A3 (en) | Fibroblast growth factor-like molecules and uses thereof | |
CA2284142A1 (en) | Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof | |
WO2001042474A3 (en) | Interferon-like molecules and uses thereof | |
WO1999002704A3 (en) | Dual specifically phosphatase and methods of use | |
WO2001016334A3 (en) | Human hydrolytic enzymes | |
WO2002062818A3 (en) | Antisense modulation of casein kinase 2-alpha expression | |
WO2002097046A3 (en) | B7 related protein-2 molecules and uses thereof | |
WO2001032888A3 (en) | Human transferase molecules | |
WO2002031132A3 (en) | 8843, a human dual specificity phosphatase family member and uses therefor | |
WO1998049317A3 (en) | Diagnosis and treatment of phosphatase- 0r kinase-related disorders | |
WO2003055980A3 (en) | Il-17 like molecules and uses thereof | |
WO1999041373A3 (en) | Human transport-associated molecules | |
WO2003070965A3 (en) | The eaat2 promoter and uses thereof | |
WO2002055725A3 (en) | Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production | |
WO1999049037A3 (en) | Protein phosphatase-related molecules | |
WO2000018916A3 (en) | Human genes and gene expression products | |
WO2001044269A3 (en) | Brain protein markers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001979662 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001979662 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |